CytomX Therapeutics

Filed a patent for "activatable cytokine constructs and combination methods" on Thu, January 23, 2025

Filed a patent for "masking polypeptides, activatable cytokine constructs, and related compositions and methods" on Wed, April 12, 2023

Filed a patent for "masking polypeptides, activatable cytokine constructs, and related compositions and methods" on Wed, April 12, 2023

Filed a patent for "activatable cytokine constructs and related compositions and methods" on Wed, April 12, 2023

Filed a patent for "activatable antibodies that bind epidermal growth factor receptor and methods of use thereof" on Thu, December 5, 2024

Filed a patent for "compositions and methods for detecting protease activity in biological systems" on Thu, October 10, 2024

Filed a patent for "activatable cytokine constructs and related compositions and methods" on Tue, April 2, 2024

Filed a patent for "trimeric activatable cytokine constructs and related compositions and methods" on Wed, April 3, 2024

Filed a patent for "method for determining protease activity in a biological sample" on Tue, February 27, 2024

Filed a patent for "matrix metalloprotease-cleavable and serine or cysteine protease-cleavable substrates and methods of use thereof" on Thu, July 18, 2024

Filed a patent for "modified antibody compositions, methods of making and using thereof" on Thu, July 11, 2024

Filed a patent for "anti-slc34a2 antibodies, antibody drug conjugates, and methods of use thereof" on Thu, March 9, 2023

Filed a patent for "epcam immunoconjugates and uses thereof" on Tue, July 12, 2022

Filed a patent for "protease-cleavable substrates and methods of use thereof" on Mon, August 1, 2022

Filed a patent for "protease-cleavable moieties and methods of use thereof" on Mon, August 1, 2022

Filed a patent for "protease-cleavable substrates and methods of use thereof" on Mon, August 1, 2022

Filed a patent for "protease-cleavable moieties and methods of use thereof" on Mon, August 1, 2022

Filed a patent for "protease-cleavable moieties and methods of use thereof" on Mon, August 1, 2022

Filed a patent for "antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof" on Thu, February 16, 2023

Filed a patent for "activatable polypeptide complex" on Thu, June 8, 2023

Filed a patent for "activatable polypeptide complex" on Thu, June 15, 2023

Filed a patent for "matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof" on Thu, July 6, 2023

Filed a patent for "proproteins and methods of use thereof" on Thu, June 15, 2023

Filed a patent for "anti-cd71 activatable antibody drug conjugates and methods of use thereof" on Thu, April 11, 2024

Filed a patent for "masked activatable cytokine constructs and related compositions and method" on Thu, April 18, 2024